Drug and Gene Delivery Devices Market to Hit USD 815 Bn by 2030

NEXT STORY
23andMe Announces the Appointment of Joseph R. Arron, M.D., Ph.D. as Chief Scientific Officer
PREV STORY
Dr. Henry Ji to Participate in the CEO Fireside Chat Evercore ISI 4th Annual HealthCONx Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program

RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader ...

author_avatar
NASDAQ Market News

Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806

SAN DIEGO and TORONTO and SEOUL, South Korea, Sept. 12, 2017 (GLOBE NEWSWIRE) -- ...

author_avatar
NASDAQ Market News

BioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement

MALVERN, Pa., July 20, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...

author_avatar
NASDAQ Market News